Literature DB >> 34129804

Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Anjira S Ambade1, Paul M Hassoun1, Rachel L Damico1.   

Abstract

The extracellular matrix (ECM), a highly organized network of structural and nonstructural proteins, plays a pivotal role in cellular and tissue homeostasis. Changes in the ECM are critical for normal tissue repair, whereas dysregulation contributes to aberrant tissue remodeling. Pulmonary arterial hypertension is a severe disorder of the pulmonary vasculature characterized by pathologic remodeling of the pulmonary vasculature and right ventricle, increased production and deposition of structural and nonstructural proteins, and altered expression of ECM growth factors and proteases. Furthermore, ECM remodeling plays a significant role in disease progression, as several dynamic changes in its composition, quantity, and organization are documented in both humans and animal models of disease. These ECM changes impact vascular cell biology and affect proliferation of resident cells. Furthermore, ECM components determine the tissue architecture of the pulmonary and myocardial vasculature as well as the myocardium itself and provide mechanical stability crucial for tissue homeostasis. However, little is known about the basement membrane (BM), a specialized, self-assembled conglomerate of ECM proteins, during remodeling. In the vasculature, the BM is in close physical association with the vascular endothelium and smooth muscle cells. While in the myocardium, each cardiomyocyte is enclosed by a BM that serves as the interface between cardiomyocytes and the surrounding interstitial matrix. In this review, we provide a brief overview on the current state of knowledge of the BM and its ECM composition and their impact on pulmonary vascular remodeling and right ventricle dysfunction and failure in pulmonary arterial hypertension.

Entities:  

Keywords:  basement membrane; extracellular matrix; pulmonary arterial hypertension; right ventricle; vascular remodeling

Mesh:

Substances:

Year:  2021        PMID: 34129804      PMCID: PMC8485997          DOI: 10.1165/rcmb.2021-0091TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  191 in total

1.  Cardiomyopathy associated with microcirculation dysfunction in laminin alpha4 chain-deficient mice.

Authors:  Jianming Wang; Masahiko Hoshijima; Jason Lam; Zhongjun Zhou; Anna Jokiel; Nancy D Dalton; Kjell Hultenby; Pilar Ruiz-Lozano; John Ross; Karl Tryggvason; Kenneth R Chien
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

Review 2.  Extracellular matrix communication and turnover in cardiac physiology and pathology.

Authors:  Abhijit Takawale; Siva S V P Sakamuri; Zamaneh Kassiri
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

3.  Expression of laminin alpha2 chain during normal and pathological growth of myocardium in rat and human.

Authors:  P Oliviéro; C Chassagne; N Salichon; A Corbier; G Hamon; F Marotte; D Charlemagne; L Rappaport; J L Samuel
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

4.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

Review 5.  Pulmonary vascular remodeling in pulmonary hypertension.

Authors:  Rubin M Tuder
Journal:  Cell Tissue Res       Date:  2016-12-26       Impact factor: 5.249

6.  Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.

Authors:  Rachel Damico; Todd M Kolb; Lidenys Valera; Lan Wang; Traci Housten; Ryan J Tedford; David A Kass; Nicholas Rafaels; Li Gao; Kathleen C Barnes; Raymond L Benza; James L Rand; Rizwan Hamid; James E Loyd; Ivan M Robbins; Anna R Hemnes; Wendy K Chung; Eric D Austin; M Bradley Drummond; Stephen C Mathai; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

7.  Mechanics and Function of the Pulmonary Vasculature: Implications for Pulmonary Vascular Disease and Right Ventricular Function.

Authors:  Steven Lammers; Devon Scott; Kendall Hunter; Wei Tan; Robin Shandas; Kurt R Stenmark
Journal:  Compr Physiol       Date:  2012-01-01       Impact factor: 9.090

Review 8.  Role of extracellular matrix proteins in heart function.

Authors:  V Pelouch; I M Dixon; L Golfman; R E Beamish; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

9.  Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.

Authors:  Muneyoshi Okada; Toshiyuki Harada; Ryuta Kikuzuki; Hideyuki Yamawaki; Yukio Hara
Journal:  J Pharmacol Sci       Date:  2009-10-06       Impact factor: 3.337

10.  Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats.

Authors:  Akira Sugiyama; Ayaka Mitsui; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2019-02-07       Impact factor: 1.267

View more
  4 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.

Authors:  Sue Gu; Claudia Mickael; Rahul Kumar; Michael H Lee; Linda Sanders; Biruk Kassa; Julie Harral; Jason Williams; Kirk C Hansen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

3.  Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.

Authors:  Di Chen; Hui-Fang Zhang; Tian-Yi Yuan; Shu-Chan Sun; Ran-Ran Wang; Shou-Bao Wang; Lian-Hua Fang; Yang Lyu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2022-02-21       Impact factor: 7.169

4.  Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure.

Authors:  Somanshu Banerjee; Jason Hong; Soban Umar
Journal:  Front Cardiovasc Med       Date:  2022-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.